Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  ferumoxytol
Find trials that include:  Any drugs shown
Results 1-7 of 7 for your search:
Start Over
Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors before or after Treatment in Patients with Primary or Metastatic Brain Tumors
Phase: Phase II
Type: Diagnostic
Age: 18 to 75
Trial IDs: 2864, NCI-2015-00225, SOL-06077-L, NCT00659126
Ferumoxytol Enhanced MRI in Detecting Lymph Node Metastases in Patients with Prostate, Bladder, or Kidney Cancer
Phase: Phase II
Type: Diagnostic
Age: 18 and over
Trial IDs: 14-C-0107, NCI-2014-02482, NCT02141490
Ferumoxytol in Improving MR Imaging in Patients with High-Grade Brain Tumors or Cerebral Metastases
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: 813, NCI-2015-00226, NCT00980720, ONC-03095-LX, OHSU-813, 6537, NCI-6537, OHSU-8097, NCT00103038
DSC-MRI with Ferumoxytol and DCE-MRI with Gadolinium in Imaging Vascular Properties in Younger Patients with Brain Tumors
Phase: No phase specified
Type: Diagnostic
Age: 18 and under
Trial IDs: 5405, NCI-2015-00227, 1562, 2864, 813, SOL-09064-LX, NCT00978562
Ferumoxytol-Labeled Magnetic Resonance Imaging in Differentiating Bone Sarcomas and Osteomyelitis
Phase: No phase specified
Type: Diagnostic
Age: 10 to 21
Trial IDs: PEDSBONE0006, NCI-2011-01367, 20253, NCT01336803
Ferumoxytol Non-stoichiometric Magnetite-Enhanced Magnetic Resonance Lymph Node Imaging in Diagnosing Patients with Cancer
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: 2012-0926, NCI-2014-02435, NCT01815333
Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients with Glioblastoma
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: 9846, NCI-2015-00080, eIRB#9846, SOL-13090-L, NCT02359097
Start Over